Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBX129801 in T1DM with Diabetic Peripheral Neuropathy
NCT01681290Phase 2Completed
- Sponsor
- Cebix
- Start
- Oct 2012
- Primary completion
- Nov 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of Pegylated synthetic human C-peptide in diabetic peripheral neuropathy (DPN), sponsored by Cebix. Started Oct 2012; status: completed.
02
Drugs
Pegylated synthetic human C-peptide
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01681290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01681290.